Investors

Date	Name	Title	Type	Shares Traded	Price Range
Dec 17, 2010	goldberg murray a	Officer	Automatic Sell	5,168	32.15
Dec 17, 2010	brown michael s	Director	Automatic Sell	2,897	32.44
Dec 20, 2010	brown michael s	Director	Automatic Sell	2,103	32.89 - 33.24
Jan 4, 2013	goldstein joseph l	Director	Option Execute	5,000	33.42
Jan 6, 2011	goldberg murray a	Officer	Automatic Sell	12,627	33.79
Jan 7, 2011	goldberg murray a	Officer	Automatic Sell	7,373	33.95 - 34.14
Jan 14, 2011	roberts william	Officer	Automatic Sell	5,795	33.99 - 34.49
Jan 6, 2011	vagelos p roy	Director	Automatic Sell	21,043	34.04
Jan 3, 2011	vagelos p roy	Director	Automatic Sell	8,957	34.04
Jan 7, 2011	roberts william	Officer	Automatic Sell	5,393	34.17
Jan 26, 2011	goldstein joseph l	Director	Automatic Sell	4,599	34.35
Jan 26, 2011	roberts william	Officer	Automatic Sell	2,693	34.49
Jan 19, 2011	roberts william	Officer	Automatic Sell	1,399	34.61 - 35.42
Jan 27, 2011	goldstein joseph l	Director	Automatic Sell	5,401	34.67
Jan 18, 2011	brown michael s	Director	Automatic Sell	4,845	34.88
Jan 18, 2011	roberts william	Officer	Automatic Sell	14,720	34.88 - 34.99
Jan 18, 2011	shooter eric m	Director	Automatic Sell	15,000	35.00
Jan 18, 2011	van plew daniel p	Officer	Automatic Sell	25,000	35.22
Feb 10, 2011	goldstein joseph l	Director	Automatic Sell	2,239	35.27
Jan 19, 2011	brown michael s	Director	Automatic Sell	5,155	35.59 - 35.60
Showing 381-400 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.